Oral gefitinib plus methotrexate is not clinically superior to methotrexate for tubal ectopic pregnancy.

Published Date: 17 Feb 2023

A new study found that oral gefitinib plus parenteral methotrexate was no more clinically effective than methotrexate alone. Search results...

Read Full News

Latest News

Extending Postpartum Monitoring Reduces Severe Complications

Extending the surveillance period past the delivery period to 6 weeks postpartum would align with World Health Organization practices.

Mosaicism Reporting Lacks Predictive Value for Live Birth

Use of mosaicism as measured by preimplantation genetic testing for aneuploidy does not predict chances of live birth after IVF.

IV Ferumoxytol Beats Oral Iron for Pregnancy Anemia

Intravenous ferumoxytol shows higher efficacy than oral iron in the treatment of anemia in pregnant women, improving hemoglobin at delivery and achieving better anemia resolution.

PRP Injection Improves Female Sexual Function

Platelet-rich plasma injections into the anterior vaginal wall enhance sexual function in premenopausal women.

Group and Individual Prenatal Care Yield Similar Experiences

No differences were observed between the two care models.

Male Factors, Female Burden: Rethinking Infertility Care

Delayed childbearing has increased pregnancies after age 35, and while assisted reproduction expands options, older parenthood raises clinical, social, and policy challenges.

Todays Updates

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

A dose-dense modified Stanford V regimen may improve early complete responses and allow some pediatric patients with low-risk Hodgkin lymphoma to skip radiotherapy.

Older Age Alone Does Not Limit Adagrasib Benefit in NSCLC

In a small phase II study of patients with KRAS G12C-mutated NSCLC, poor performance status, not advanced age, was associated with reduced treatment response.

Todays Updates

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

A dose-dense modified Stanford V regimen may improve early complete responses and allow some pediatric patients with low-risk Hodgkin lymphoma to skip radiotherapy.

Older Age Alone Does Not Limit Adagrasib Benefit in NSCLC

In a small phase II study of patients with KRAS G12C-mutated NSCLC, poor performance status, not advanced age, was associated with reduced treatment response.

Latest News

Extending the surveillance period past the delivery period to 6 weeks postpartum would align with World Health Organization practices.

Use of mosaicism as measured by preimplantation genetic testing for aneuploidy does not predict chances of live birth after IVF.

Intravenous ferumoxytol shows higher efficacy than oral iron in the treatment of anemia in pregnant women, improving hemoglobin at delivery and achieving better anemia resolution.

Platelet-rich plasma injections into the anterior vaginal wall enhance sexual function in premenopausal women.

No differences were observed between the two care models.

Delayed childbearing has increased pregnancies after age 35, and while assisted reproduction expands options, older parenthood raises clinical, social, and policy challenges.

News All Time

Older C-Section Surgical Technique May Reduce Complications

As the number of cesarean sections has increased over the past 30 years, a faster surgical closure technique has gained widespread use but may increase long-term complications.

Menstruation topic still stigmatized by younger generation in Spain, study finds

The menstrual taboo persists. This is the main conclusion of a pioneering macro-study in Spain involving more than 4,000 participants and led by the INGENIO Institute, a joint center of the Spanish National Research Council ...

Research team develops actionable tool to assess risk for premature births

Researchers at NYU and partners within the International Healthy Outcomes of Pregnancy for Everyone (HOPE) Consortium have developed a novel tool, the Preterm Birth Actionable Risk Index (PTB-ARIx), designed to identify pregnant ...

AHA: Study examines impact of adequate prenatal care for congenital heart disease

For cases of mild congenital heart defects (CHDs), more prenatal visits are associated with lower probability of delivery at a cardiac center, according to a study published online Nov. 9 in JAMA Network Open to coincide ...

Severe nausea during pregnancy and depression: Study reveals bidirectional association

A recent study conducted at the University of Turku in Finland showed that hyperemesis gravidarum, a severe form of nausea that occurs during pregnancy, is linked to depression. Women who experienced severe nausea were more ...

Common cesarean closure method linked to long-term complications, experts suggest change

The most common technique used for closing the uterus after a cesarean delivery causes so many long-term complications that it's time to question its use. That's the conclusion reached by two world-renowned specialists in ...

From post-partum depression to relationship woes: The importance of mental health after giving birth

"Postpartum depression" has been discussed as an identifiable, measurable, treatable disorder for 50 years now. Thresholds, scales, prevalence rates: everything seems clear, even reassuring.

Researchers call for greater clarity around prenatal screening forms

A new Australian study has found that forms used for one of the most common genetic screening tests in pregnancy—costing prospective parents up to $550—are often confusing and inconsistent, blurring the lines between ...

Pain during a C-section? New study challenges fears about general anesthesia

Regional anesthesia—typically with a spinal or epidural block—has long been favored for cesarean births due in part to concerns about the effects that general anesthesia may have on newborns during labor and delivery. ...

Majority of Georgia women surveyed would support abortion at 14 weeks, beyond the current legal limit

Among a cross-sectional group of women of reproductive age in Georgia, 76% supported the legality of abortion access at six weeks and 60% supported it at 14 weeks, according to a new study published in the open-access journal ...

Why anti-estrogen therapy fails in ovarian cancer, and how to make it work

Scientists at The Wistar Institute have solved a longstanding puzzle in ovarian cancer treatment: why anti-estrogen therapy often fails even when tumors express the hormone receptor that should make them responsive. The study ...

Self-guided hypnosis can significantly reduce menopausal hot flashes

Can a simple daily audio hypnosis session help women find relief from one of menopause's most disruptive symptoms—hot flashes—without medication? A new clinical trial led by Baylor University's Gary R. Elkins, Ph.D., ...

Husbands' self-esteem linked to lower risk of preterm birth in partners

A husband's optimism and confidence may play a crucial, if often unseen, role in helping babies arrive healthy and on time.

After Dobbs, Illinois abortion clinics saw surge in out-of-state patients

Following the Supreme Court's decision in Dobbs v. Jackson Women's Health Organization, two large Illinois abortion providers saw a 35% increase in abortions, driven by out-of-state patients who lived where abortion care ...

Study shows good British Columbia abortion pill access, but gaps remain

Most pharmacies in British Columbia can provide the abortion pill mifepristone within days, but uneven access still leaves some women facing barriers to this time-sensitive medication, according to new research.

Sexual dysfunction in women at midlife explored by largest study of its kind

Almost 50% of women in midlife surveyed in a Monash University-led study had poor sexual well-being, including a doubling of the likelihood of desire and arousal dysfunction in early perimenopausal women from premenopause.

Recommended News For You

Best foot forward—chemo care should include podiatry, say researchers

Study: For predicting breast cancer, AI performs better than traditional risk models.

The need for more Latinx participants in Alzheimer's trials is urgent.

Single-dose radiation before surgery can eradicate breast cancer

Breast cancer: A new target to eliminate dormant cells before they wake

FDA Approves Hemophilia B Second Gene Therapy.

ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer

Recommended Articles For You

Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making 

Optimizing Platelet Transfusions: Balancing Benefits and Risks in Modern Hematology 

Mastering Modern Oncology: Accreditation, Education, and Research Trends for 2025 

Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Global inequalities found in cancer research funding

2.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

3.

Review looks at potential treatment targets in the tumor microenvironment.

4.

Accurately identified high-grade prostate cancer through urine testing.

5.

Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.

1.

Ticagrelor Monotherapy vs. Ticagrelor + Aspirin in ACS Post-PCI: ULTIMATE-DAPT Trial

2.

AI-Driven Chemotherapy: Transforming Cancer Care with Precision and Efficiency

3.

Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics

4.

Epigenetics and Resistance: Mechanisms in Histone Methylation-Targeted Therapies

5.

Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A New Era in Managing Cancer-Associated Thrombosis

2.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

3.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

4.

Efficient Management of First line ALK-rearranged NSCLC - Part III

5.

Newer Immunotherapies for Myeloma- A Comprehensive Overview


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot